ArticleNature structural & molecular biology2021
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Open access · bronzeAbstract readPublished Erratum
In one paragraph
Article in Nature structural & molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 14 citations in OpenAlex.
- Nanobodies with cross-neutralizing activity provide prominent therapeutic efficacy in mild and severe COVID-19 rodent models.Virologica Sinica · 2023Article
- Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection.Frontiers in immunology · 2023Article
- Research progress and applications of nanobody in human infectious diseases.Frontiers in pharmacology · 2022Review
Corrections and comments
- Erratum for
Authors and funding
33 authors at 7 institutions in 1 country.
Jiandong HuoStructural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK.
Audrey Le BasDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
Reinis R RuzaDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
Helen M E DuyvesteynDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
Halina MikolajekDiamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
Tomas MalinauskasDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.ORCID http://orcid.org/0000-0002-4847-5529
Tiong Kit TanMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.ORCID http://orcid.org/0000-0001-8746-8308
Pramila RijalMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Maud DumouxStructural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK.ORCID http://orcid.org/0000-0002-1732-1041
Philip N WardDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.ORCID http://orcid.org/0000-0003-2546-3426
Jingshan RenDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
Daming ZhouDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
Peter J HarrisonDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
Miriam WeckenerStructural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK.
Daniel K ClareDiamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
Vinod K VogiralaDiamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
Julika RadeckeDiamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
Lucile MoyniéStructural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK.
Yuguang ZhaoDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.ORCID http://orcid.org/0000-0001-8916-8552
Javier Gilbert-JaramilloSir William Dunn School of Pathology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-1268-2304
Michael L KnightSir William Dunn School of Pathology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8780-1630
Julia A TreeNational Infection Service, Public Health England, Porton Down, Salisbury, UK.
Karen R ButtigiegNational Infection Service, Public Health England, Porton Down, Salisbury, UK.
Naomi CoombesNational Infection Service, Public Health England, Porton Down, Salisbury, UK.
Michael J ElmoreNational Infection Service, Public Health England, Porton Down, Salisbury, UK.
Miles W CarrollNational Infection Service, Public Health England, Porton Down, Salisbury, UK.
Loic CarriqueDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.ORCID http://orcid.org/0000-0001-5332-8593
Pranav N M ShahDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.ORCID http://orcid.org/0000-0003-1212-904X
William JamesSir William Dunn School of Pathology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2506-1198
Alain R TownsendMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
David I StuartDivision of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.ORCID http://orcid.org/0000-0002-3426-4210
Raymond J OwensStructural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK. raymond.owens@rc-harwell.ac.uk.
James H NaismithStructural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK. naismith@strubi.ox.ac.uk.ORCID http://orcid.org/0000-0001-6744-5061
Centre for Human Genetics · GBPublic Health England · GBDiamond Light Source · GBRosalind Franklin Institute · GBUniversity of Oxford · GBAcademy of Medical Sciences · GBJohn Radcliffe Hospital · GB
Funding
Medical Research Council G1100525Medical Research Council MR/N00065X/1Medical Research Council MR/V001329/1
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.